| Code | Description | Claims | Beneficiaries | Total Paid |
| 93976 |
|
19,416 |
18,517 |
$2.13M |
| 76830 |
Ultrasound, transvaginal |
20,072 |
19,236 |
$1.31M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,492 |
17,203 |
$1.26M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,040 |
4,040 |
$365K |
| 59426 |
|
337 |
337 |
$298K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15,588 |
15,538 |
$254K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,470 |
15,421 |
$249K |
| 76818 |
|
2,758 |
1,497 |
$244K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,437 |
2,979 |
$228K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,869 |
1,869 |
$180K |
| 99385 |
|
1,523 |
1,523 |
$160K |
| 82670 |
|
8,016 |
8,010 |
$147K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
3,980 |
3,965 |
$129K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,267 |
6,267 |
$122K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,920 |
1,885 |
$120K |
| 87480 |
|
11,672 |
11,620 |
$117K |
| 87660 |
|
11,631 |
11,581 |
$116K |
| 84144 |
|
8,660 |
8,492 |
$115K |
| 84403 |
|
6,695 |
6,691 |
$112K |
| 83001 |
|
7,895 |
7,888 |
$96K |
| 82627 |
|
6,745 |
6,739 |
$95K |
| 87510 |
|
9,619 |
9,576 |
$93K |
| 84146 |
|
6,930 |
6,895 |
$87K |
| 83002 |
|
7,339 |
7,334 |
$87K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,846 |
5,818 |
$82K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,051 |
974 |
$80K |
| 84702 |
|
8,524 |
8,233 |
$74K |
| 86703 |
|
8,215 |
8,207 |
$73K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
657 |
657 |
$68K |
| 82728 |
|
7,581 |
7,569 |
$66K |
| 82607 |
|
7,477 |
7,465 |
$63K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
886 |
811 |
$63K |
| 82746 |
|
7,490 |
7,478 |
$62K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,225 |
1,163 |
$53K |
| 87340 |
|
7,218 |
7,213 |
$48K |
| 76820 |
|
1,660 |
943 |
$47K |
| 84439 |
|
8,253 |
8,238 |
$47K |
| 86708 |
|
6,735 |
6,729 |
$45K |
| 86803 |
|
6,420 |
6,415 |
$44K |
| 84481 |
|
6,366 |
6,359 |
$43K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,404 |
6,399 |
$42K |
| 87481 |
|
5,110 |
4,053 |
$38K |
| 80050 |
General health panel |
2,503 |
2,499 |
$38K |
| 80053 |
Comprehensive metabolic panel |
5,166 |
5,157 |
$36K |
| J7300 |
Intrauterine copper contraceptive (paragard) |
39 |
39 |
$34K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
292 |
292 |
$30K |
| 83615 |
|
9,027 |
9,010 |
$30K |
| 83550 |
|
7,588 |
7,576 |
$29K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
923 |
922 |
$27K |
| 00952 |
|
167 |
162 |
$26K |
| 83540 |
|
7,588 |
7,576 |
$26K |
| 84550 |
|
9,051 |
9,034 |
$26K |
| 87625 |
|
1,000 |
999 |
$26K |
| 81513 |
|
182 |
181 |
$25K |
| 76813 |
|
239 |
238 |
$23K |
| 86304 |
|
1,579 |
1,574 |
$22K |
| 99386 |
|
173 |
173 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,152 |
8,047 |
$20K |
| 87563 |
|
619 |
618 |
$18K |
| 86593 |
|
6,710 |
6,706 |
$16K |
| 57150 |
|
322 |
319 |
$16K |
| 82378 |
|
1,098 |
1,098 |
$14K |
| 87653 |
|
959 |
957 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
110 |
104 |
$12K |
| 81025 |
|
4,399 |
4,117 |
$12K |
| 00940 |
|
83 |
81 |
$11K |
| 99442 |
|
180 |
179 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
55 |
55 |
$8K |
| 81002 |
|
5,387 |
4,828 |
$8K |
| 59430 |
|
40 |
40 |
$8K |
| 86696 |
|
929 |
927 |
$8K |
| 88142 |
|
967 |
966 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,158 |
1,155 |
$7K |
| 82105 |
|
1,111 |
1,111 |
$5K |
| 58300 |
|
52 |
52 |
$5K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
429 |
428 |
$4K |
| 86677 |
|
649 |
649 |
$4K |
| 86777 |
|
346 |
346 |
$3K |
| 86644 |
|
345 |
345 |
$3K |
| 86695 |
|
560 |
558 |
$3K |
| 86778 |
|
346 |
346 |
$3K |
| 84270 |
|
319 |
319 |
$3K |
| 86762 |
|
325 |
325 |
$3K |
| 86765 |
|
344 |
344 |
$3K |
| 87081 |
|
958 |
956 |
$2K |
| 86645 |
|
344 |
344 |
$2K |
| 57454 |
|
16 |
16 |
$2K |
| 86787 |
|
324 |
324 |
$2K |
| 86735 |
|
312 |
312 |
$2K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
41 |
40 |
$1K |
| 87102 |
|
170 |
170 |
$1K |
| 82950 |
|
329 |
328 |
$1K |
| 80061 |
Lipid panel |
188 |
188 |
$968.12 |
| 83721 |
|
200 |
200 |
$552.79 |
| 57465 |
|
12 |
12 |
$500.83 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
101 |
52 |
$459.81 |
| 87905 |
|
156 |
156 |
$254.85 |
| 80074 |
|
19 |
19 |
$27.28 |